Partial omission of bleomycin for early‐stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?
暂无分享,去创建一个
C. Pinnix | S. Neelapu | J. Gunther | B. Dabaja | H. Lee | L. Nastoupil | P. Strati | R. Nair | R. Steiner | P. Fang | K. Christopherson | S. Ahmed | G. Glober | Saira S. Ahmed